In most donors, immune checkpoint receptors were expressed by few trNK cells and ILCs at all locations, whereas CD8+ TRM cells displayed high immune checkpoint receptor expression in the tumor tissues (Figure 3a, b). The gene discussed is CD8A; the disease is neoplasm.